Noble Capital Markets’ Fifteenth Annual Investor / Equity Conference AUSTIN, Texas & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jan. 23, 2019– Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, today announced that its President and Chief Operating Officer, Julien Pham, MD, MPH, will deliver a presentation about the company’s unique, leading-edge […]
